sec‐Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacological Research

• Publication date

  2017-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.phrs.2016.11.030PMID 27890817PMCID PMC5352298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• sec-Butylpropylacetamide (SPD) has antimigraine properties

  2016cited by this paper
• Neuropathic pain: principles of diagnosis and treatment.

  2015cited by this paper
• Painful diabetic neuropathy

  2014cited by this paper
• Anticonvulsant medication use for the management of pain following spinal cord injury: systematic review and effectiveness analysis

  2013cited by this paper
• Immune responses of microglia in the spinal cord: contribution to pain states.

  2012cited by this paper
• Pain and immunity.

  2012cited by this paper
• Why are antiepileptic drugs used for nonepileptic conditions?

  2012cited by this paper
• P2X4 purinoceptor signaling in chronic pain

  2012cited by this paper
• A new derivative of valproic acid amide possesses a broad‐spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage

  2012cited by this paper
• TRPA1 Contributes to the Acute Inflammatory Response and Mediates Carrageenan-Induced Paw Edema in the Mouse

  2012cited by this paper
• Heterogeneity of Chronic Pain

  2012cited by this paper
• Reporting : The ARRIVE Guidelines for Reporting Animal Research

  2010cited by this paper
• Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research

  2010cited by this paper
• The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines.

  2010cited by this paper
• Interactions between the immune and nervous systems in pain

  2010cited by this paper
• Visceral versus Somatic Pain: Similarities and Differences

  2010cited by this paper
• Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.

  2009cited by this paper
• Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews.

  2009cited by this paper
• Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point‐mutated mice

  2009cited by this paper
• The Antinociceptive Effects of Anticonvulsants in a Mouse Visceral Pain Model

  2008cited by this paper
• Neuron-glia crosstalk gets serious: role in pain hypersensitivity.

  2008cited by this paper
• The neuropathic pain triad: neurons, immune cells and glia

  2007cited by this paper
• Pharmacologic management of neuropathic pain: Evidence‐based recommendations

  2007cited by this paper
• Pain Management: A Fundamental Human Right

  2007cited by this paper
• Dexketoprofen-induced antinociception in animal models of acute pain: synergy with morphine and paracetamol.

  2007cited by this paper
• Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles.

  2007cited by this paper
• Sucrose-gap technique: Advantages and limitations

  2007cited by this paper
• EFNS guidelines on pharmacological treatment of neuropathic pain

  2006cited by this paper
• Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

  2005cited by this paper
• Painful diabetic neuropathy

  2005cited by this paper
• Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain.

  2005cited by this paper
• Role of the Immune system in chronic pain

  2005cited by this paper
• Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy.

  2005cited by this paper
• Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats.

  2005cited by this paper
• Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain

  2005cited by this paper
• Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice.

  2004cited by this paper
• Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects

  2004cited by this paper
• Changes in electrophysiological properties of regenerating rat peripheral nerves after crush injury.

  2004cited by this paper
• Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels.

  2004cited by this paper
• Comparison of nerve conduction blocks by an opioid and a local anesthetic.

  2002cited by this paper
• Can we conquer pain?

  2002cited by this paper
• Bioanalytical Method Validation—A Revisit with a Decade of Progress

  2000cited by this paper
• Visceral pain: mechanisms of peripheral and central sensitization.

  1995cited by this paper
• The formalin test: an evaluation of the method

  1992cited by this paper
• An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

  1992cited by this paper
• The rat paw formalin test: comparison of noxious agents

  1990cited by this paper
• The Role of Length of Nerve Exposed to Local Anesthetics in Impulse Blocking Action

  1989cited by this paper
• Pharmacological criteria for risk-benefit evaluation of NSAIDs.

  1988cited by this paper
• The formalin test in mice: dissociation between inflammatory and non‐inflammatory pain

  1987cited by this paper
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

  1987cited by this paper
• Species differences in pharmacokinetics and drug teratogenesis.

  1986cited by this paper
• Structure-activity relationship of lidocaine homologs producing tonic and frequency-dependent impulse blockade in nerve.

  1986cited by this paper
• The rates of interaction of local anesthetics with sodium channels in nerve.

  1978cited by this paper
• Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents.

  1976cited by this paper
• Pharmacology of 2-amino-indane hydrochloride (Su-8629): a potent non-narcotic analgesic.

  1961cited by this paper
• A new method for measuring membrane potentials with external electrodes.

  1954cited by this paper
• A new method for measuring membrane potentials with external electrodes

  1954cited by this paper

• Valproic acid as a therapeutic scaffold: Advances in structural modification and drug design.

  2025cites this paper
• Repeated Valproic Acid Administration Fundamentally Ameliorated Cisplatin-Induced Mechanical Allodynia in Rats

  2025cites this paper
• Bee venom ameliorates oxidative stress and histopathological changes of hippocampus, liver and testis during status epileptics.

  2023cites this paper
• Identification of autophagy-related genes in neuropathic pain through bioinformatic analysis

  2023cites this paper
• Design and evaluation of pharmacological properties of a new 1,3,4-thiadiazolylamide derivative of 2-propylpentanoic acid

  2021influential citation
• Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile

  2021cites this paper
• Synthesis, Anticonvulsant and Antinociceptive Activity of New Hybrid Compounds: Derivatives of 3-(3-Methylthiophen-2-yl)-pyrrolidine-2,5-dione

  2020cites this paper
• Analgesic and antiallodynic activity of novel anticonvulsant agents derived from 3-benzhydryl-pyrrolidine-2,5-dione in mouse models of nociceptive and neuropathic pain.

  2019cites this paper
• Novel treatment approaches and pediatric research networks in status epilepticus.

  2019cites this paper
• Pain management in children with cerebral palsy undergoing reconstructive or palliative hip joint surgery

  2019cites this paper
• Evaluation of anticonvulsant and analgesic activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.

  2018cites this paper
• Diastereoselective Synthesis of Spirocyclopropanes under Mild Conditions via Formal [2 + 1] Cycloadditions Using 2,3-Dioxo-4-benzylidene-pyrrolidines

  2017cites this paper
• Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII)

  2017cites this paper
• Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy

  2017cites this paper
• sec-Butylpropylacetamide (SPD) has antimigraine properties

  2016cites this paper